DDW Editor Reece Armstrong speaks to Dr Neil Murray, CEO of Liverpool-based RenewVax, that is developing the first universal vaccine for invasive pneumococcal disease, as well as vaccines for other antimicrobial resistant bacterial infections. RA: What’s the current unmet need in terms of preventing and treating pneumococcal disease? NM: Streptococcus pneumoniae is one of […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!